Greg Cesarone, Ph.D., currently serves as Vice President of Specialty Lab Services at Discovery Life Sciences, overseeing the US IHC Labs as both Site Lead in Newtown and Huntsville since October 2024 and previously as Newtown Site Co-Lead from January 2022 to May 2023. Prior to this role, Greg was a Study Director at QualTek Molecular Laboratories, where responsibilities included IHC biomarker testing and assay development between October 2012 and November 2019. Additional experience includes positions as Senior Project Manager at NAXION, Project Manager at TenX Biopharma, Manager of Business Development at SHI Link, and Postdoctoral Researcher at the University of Pennsylvania. Greg holds a Ph.D. in Biochemistry and Molecular Biology from Thomas Jefferson University and a B.S. in Biology with minors in Chemistry and Computer Science from The College of New Jersey.
This person is not in the org chart
This person is not in any teams
This person is not in any offices